Calendrier des promotions Medical Marijuana, Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise Medical Marijuana, Inc.
Medical Marijuana, Inc., an investment holding company, operates in the cannabinoid-based nutraceutical industry. It focuses on the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol (CBD) and other products containing CBD-rich hemp oil; treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products; and nonpsychoactive cannabidiol products. The company is also involved in the research and development of new therapeutic agents that are designed to reduce oxidative stress and act as immuno-modulators and neuroprotectants; dietary supplements, skin care products, and prescription-based hemp oil under the Kannaway and HempMeds brands; and proprietary testing, genetics, labeling and packaging, tracking, and production and standardization methods for the medicinal cannabinoid industry. In addition, it offers RSHO oil for the treatment of various illnesses and conditions; and plant-based, non-GMO pet products for health and wellness, play and wear, and environmentally-friendly supplies. Medical Marijuana, Inc. was incorporated in 2005 and is based in San Diego, California.Paramètres de base
ISIN
US58463A1051
Industry
Health Care Providers & Services
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Sous-estimation
Nom | Signification | Grade |
P/S | 0.1363 | 10 |
P/BV | 0.0408 | 10 |
P/E | 0 | 0 |
Efficacité
Nom | Signification | Grade |
ROA | -0.934 | 0 |
ROE | -1.29 | 0 |
ROIC | 0 | 0 |
Dividendes
Nom | Signification | Grade |
Rendement en dividendes | 0 | 0 |
DSI | 0 | 0 |
Croissance moyenne du dividende | 0 | 0 |
Devoir
Nom | Signification | Grade |
Debt/EBITDA | -38.49 | 10 |
Debt/Ratio | 0.042 | 10 |
Debt/Equity | 0.3621 | 10 |
Impulsion de croissance
Nom | Signification | Grade |
Rentabilité Revenue, % | -68.22 | 0 |
Rentabilité Ebitda, % | -96.48 | 0 |
Rentabilité EPS, % | -99.69 | 0 |
paper.price.prices
Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
common.calendar.number_days.1 | 0.0002 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.7d | 0.0002 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.30d | 0.0002 $ | 0.0002 $ | 0.0002 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.90d | 0.0002 $ | 0.0002 $ | 0.0003 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.180d | 0.0004 $ | 0.0002 $ | 0.0005 $ | -50 % | 0 % | 0 % |
common.calendar.number_days.1y | 0.0012 $ | 0.0002 $ | 0.0016 $ | -83.33 % | 0 % | 0 % |
common.calendar.number_days.3y | 0.01 $ | 0.0002 $ | 0.02 $ | -98 % | 0 % | 0 % |
common.calendar.number_days.5y | 0.01 $ | 0.0002 $ | 0.17 $ | -98 % | 0 % | 0 % |
common.calendar.number_days.10y | 0.0002 $ | 0.0002 $ | 0.2299 $ | +100 % | 0 % | 0 % |
common.calendar.number_days.ytd | 0.0004 $ | 0.0002 $ | 0.0005 $ | -50 % | 0 % | 0 % |
Principaux propriétaires
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
Superviseur | Titre d'emploi | Paiement | Année de naissance |
Dr. Timothy Richard Scott Ph.D. | CEO, President & Chairman | N/A | 1953 (72 année) |
Mr. Tyler Whatcott | Chief Technology Officer | N/A | |
Ms. Michelle L. Sides Esq. | Chief Legal Officer | N/A | |
Dr. Rubens Wajnsztejn | Chief Medical Officer | N/A | |
Dr. George E. Anastassov DDS, M.D., MBA | Member of Advisory Board and Chief Executive Officer of Canchew Biotechnologies | N/A | 1963 (62 année) |
Informations sur l'entreprise
Adresse: United States, San Diego. CA, 3974 Sorrento Valley Blvd - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.medicalmarijuanainc.com
Site web: https://www.medicalmarijuanainc.com